Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04502524 · ClinicalTrials.gov registry record · Phase 1
Website Smoking Cessation Intervention for the Promotion of Smoking Cessation in Low-Income Veterans
A Phase 1 study of Cigarette Smoking-Related Carcinoma, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 53
- Enrollment target
- 1
- Study location
NCT04502524 is a Phase 1 study of Cigarette Smoking-Related Carcinoma that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 53 participants, below the 465-participant average among 21 other Cigarette Smoking-Related Carcinoma trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04502524, a Phase 1 study of Cigarette Smoking-Related Carcinoma, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 53 participants
- Enrollment target
- 1
- Study location
Study Summary
This phase I trial studies how well a new electronic (e)-health smoking cessation program (called Vet Flexiquit) works in promoting smoking cessation in low-income veterans who may or may not be ready to quit smoking. The study will compare the new website smoking cessation program to the current standard care website smoking cessation program offered by the Veterans Administration (VA). Both website interventions will be accompanied by a text messaging program that includes: (1) motivational messages, and (2) reminders to use the assigned program. Both of the website interventions can help smokers quit or cut back on how much they smoke, thus dramatically reducing their chances of developing tobacco-related health conditions.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Health Promotion and Education
- BEHAVIORAL Health Education
- BEHAVIORAL Smoking Cessation Intervention (New website)
- BEHAVIORAL Smoking Cessation Intervention (Standard of care website)
Study Locations (1)
Massachusetts
- Bedford VA Research Corporation, Inc. - Bedford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2021-02-03 |
| Est. Completion | 2022-01-28 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04502524
The ClinicalTrials.gov registry entry for NCT04502524 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 465-participant average among 21 other Cigarette Smoking-Related Carcinoma trials with a reported enrollment target (89% lower). The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cigarette Smoking-Related Carcinoma appearing as the primary indexed condition, and to 5 interventions - of which Questionnaire Administration is the first listed.
NCT04502524 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04502524 about?
NCT04502524 is a clinical study titled "Website Smoking Cessation Intervention for the Promotion of Smoking Cessation in Low-Income Veterans". This phase I trial studies how well a new electronic (e)-health smoking cessation program (called Vet Flexiquit) works in promoting smoking cessation in low-income veterans who may or may not be ready to quit smoking. The study will compare the new website smoking cessation program to the current st...
What is the current status of trial NCT04502524?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 53 participants. The study started on 2021-02-03. Estimated completion is 2022-01-28.
What conditions does trial NCT04502524 study?
This clinical trial studies the following conditions: Cigarette Smoking-Related Carcinoma.
What interventions are being tested in trial NCT04502524?
The interventions under investigation include: Questionnaire Administration (OTHER), Health Promotion and Education (OTHER), Health Education (BEHAVIORAL), Smoking Cessation Intervention (New website) (BEHAVIORAL), Smoking Cessation Intervention (Standard of care website) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04502524?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04502524 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cigarette Smoking-Related Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking, IndigeQuit Trial
RECRUITING · NA
-
Carcinogen and Toxicant Exposure Among Young Adults Who Co-Use E-cigarettes and Cannabis (Co-Tox Study)
RECRUITING
-
Sensory Tests of Cigarettes for Identification of Flavors in Current Daily Smoking Adults
RECRUITING · Early Phase 1
-
Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
RECRUITING · Phase 4
-
Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers
RECRUITING · Phase 2
-
CONNECTing to LungCare
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.